يعرض 1 - 6 نتائج من 6 نتيجة بحث عن '"Bacterial meningitis"', وقت الاستعلام: 1.57s تنقيح النتائج
  1. 1
  2. 2
  3. 3

    المساهمون: Centre de Recherche Médicale et Sanitaire (Niamey, Niger) (CERMES), Réseau International des Instituts Pasteur (RIIP), Direction de la Surveillance et de la Riposte aux Epidémies, Ministère de la Santé Publique [Niger], Risques, Epidémiologie, Territoire, INformations, Education et Santé (RETINES), COMUE Université Côte d'Azur (2015-2019) (COMUE UCA)-Université Côte d'Azur (UCA)

    المصدر: The Pan African Medical Journal
    The Pan African Medical Journal, Pan African Medical Center for Public Health Research and Information, 2018, 30, ⟨10.11604/pamj.2018.30.235.15937⟩
    Pan African Medical Journal; Vol. 30 No. 1 (2018)

    وصف الملف: application/pdf

  4. 4

    المساهمون: AII - Infectious diseases, Medical Microbiology and Infection Prevention, European Centre for Disease Prevention and Control [Stockholm, Sweden] (ECDC), Tufts University [Medford], Hellenic Centre for Diseases Control and Prevention (HCDCP), Members of the ECDC network for invasive meningococcal disease: Elisabeth Kanitz, Lukas Richter (Austria), Wesley Mattheus, Corinne Bleyenheuft (Belgium), Teodora Georgieva, Ivan Simeonovski (Bulgaria), Vesna Višekruna Vučina, Sanja Kurečić Filipović (Croatia), Maria Koliou, Despo Pieridou Bagatzouni (Cyprus), Pavla Krizova, HelenaSebestova (Czech Republic), Steen Hoffmann, PalleValentiner-Branth (Denmark), Natalia Kerbo, Rita Peetso (Estonia), Markku Kuusi, Maija Toropainen (Finland), Isabelle Parent, Muhamed-Kheir Taha (France), Ulrich Vogel, Wiebke Hellenbrand (Germany), Theano Georgakopoulou, Georgina Tzanakaki (Greece), Katalin Krisztalovics, Tamás Tirczka (Hungary), Thorolfur Gudnason, Hjordis Hardardottir (Iceland), Piaras O'Lorcain, Desiree Bennett (Ireland), Fortunato D'Ancona, Paola Stefanelli (Italy), Larissa Savrasova, Darja Vasilevska (Latvia), Nerija Kuprevičienė, Rasa Liausedienė (Lithuania), Irène Demuth, Gérard Scheiden (Luxembourg), Jackie Maistre Melillo, Paul Caruana (Malta), Arievan der Ende, Liesbeth Mollema (Netherlands), Dominique Caugant, Hans Blystad (Norway), Anna Skoczyńska (Poland), Lavinia Zota, Marina Pana (Romania), Marta Grgič Vitek, Metka Paragi (Slovenia), Rosa Cano, Raquel Abad (Spain), Tiia Lepp (Sweden), Helen Campbell (UK)

    المصدر: Vaccine, 35(16), 2034-2041. Elsevier BV
    Vaccine
    Vaccine, 2017, 35 (16), pp.2034-2041. ⟨10.1016/j.vaccine.2017.03.007⟩

    مصطلحات موضوعية: 0301 basic medicine, Male, Pediatrics, Epidemiology, MESH: Meningococcal Vaccines/administration & dosage, First year of life, Neisseria meningitidis, medicine.disease_cause, 0302 clinical medicine, MESH: Aged, 80 and over, MESH: Child, Medicine, 030212 general & internal medicine, MESH: Incidence, Child, MESH: Aged, Aged, 80 and over, education.field_of_study, Surveillance, MESH: Middle Aged, Incidence, MESH: Sex Distribution, Invasive meningococcal disease (IMD), Middle Aged, MESH: Infant, MESH: Sepsis/epidemiology, Vaccination, Europe, Infectious Diseases, Invasive meningococcal disease, MESH: Young Adult, Child, Preschool, Molecular Medicine, Bacterial meningitis, Female, Adult, medicine.medical_specialty, Adolescent, 030106 microbiology, Population, Meningococcal Vaccines, MESH: Meningitis, Meningococcal/epidemiology, Meningitis, Meningococcal, Serogroup, 03 medical and health sciences, Young Adult, Age Distribution, Environmental health, MESH: Meningitis, Meningococcal/prevention & control, Sepsis, Humans, Sex Distribution, education, MESH: Age Distribution, Aged, MESH: Adolescent, MESH: Humans, General Veterinary, General Immunology and Microbiology, business.industry, MESH: Child, Preschool, Public Health, Environmental and Occupational Health, Infant, MESH: Adult, MESH: Serogroup, MESH: Male, MESH: Europe/epidemiology, MESH: Neisseria meningitidis/isolation & purification, [SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologie, MESH: Neisseria meningitidis/classification, business, Notification rate, MESH: Female

  5. 5

    المساهمون: Finlay Institute of Vaccines, Public Health England [London], Norwegian Institute of Public Health [Oslo] (NIPH), University of the East – Ramon Magsaysay Memorial Medical Center [Philippines], Faculty of Medicine [Hacettepe University], Hacettepe University = Hacettepe Üniversitesi, University of Bristol [Bristol], Université Laval [Québec] (ULaval), Eskisehir Osmangazi University, National Institute of Public Health = Instituto Nacional de Salud Pública [Cuernavaca, Mexique] (INSP), Ministry of Health [Riyadh], National Institute of Infectious Diseases [Tokyo], University of Cambridge [UK] (CAM), National Institute for Communicable Diseases [Johannesburg] (NICD), Central Research Institute of Epidemiology [Moscow], FCM Santa Casa de São Paulo School of Medical Sciences [São Paulo], Chinese Centre for Disease Control and Prevention, Meningitis Research Foundation [Bristol], Universität Zürich [Zürich] = University of Zurich (UZH), Örebro University Hospital [Örebro, Sweden], Centre National de Référence des Méningocoques et Haemophilus influenzae - National Reference Center Meningococci and Haemophilus influenzae (CNR), Institut Pasteur [Paris], Institute of Health Carlos III, R. Borrow, J. Lucidarme and X. Bai perform contract work for Public Health England on behalf of GSK, PATH, Sanofi Pasteur and Pfizer. M.K. Taha performs contract work for the Institut Pasteur funded by GSK, Pfizer and Sanofi Pasteur. S. Meiring has received grant funding for a meningococcal carriage study by Sanofi Pasteur. G. Enchaniz-Aviles has received support for research projects from GSK and Pfizer. J.A. Vázquez performs contract work for the Institute of Health Carlos III funded by GSK and Pfizer. P. De Wals has received research grants, and reimbursements of travel expenses from vaccine manufacturers including GSK, Novartis, Sanofi Pasteur, and Pfizer, as well as from governmental agencies including the Quebec Ministry of Health and Social Services, Health Canada, and the Public Health Agency of Canada. M.A.P. Sáfadi has received grants to support research projects and consultancy fees from GSK, Pfizer and Sanofi Pasteur. C. Trotter has received consulting fees from GSK and an honorarium from Sanofi-Pasteur for developing and delivering a modeling workshop at a previous GMI meeting. H. Christensen has received reimbursements of travel expenses and, for previous GMI meetings, honoraria, from Sanofi-Pasteur, consultancy fees from IMS Health and AstraZeneca all paid to her employer. She is supported by the NIHR Health Protection Research Unit in Evaluation of Interventions at the University of Bristol. The views expressed in this article are those of the author(s) and not necessarily those of the NHS, the NIHR, or the Department of Health and Social Care., Institut Pasteur [Paris] (IP), Sanofi Pasteur

    المصدر: Expert Review of Vaccines
    Expert Review of Vaccines, Expert Reviews (formerly Future Drugs), 2018, 18 (1), pp.15-30. ⟨10.1080/14760584.2019.1557520⟩
    Acevedo, R, Bai, X, Borrow, R, Caugant, D A, Carlos, J, Ceyhan, M, Christensen, H, Climent, Y, De Wals, P, Dinleyici, E C, Echaniz-Aviles, G, Hakawi, A, Kamiya, H, Karachaliou, A, Lucidarme, J, Meiring, S, Mironov, K, Sáfadi, M A P, Shao, Z, Smith, V, Steffen, R, Stenmark, B, Taha, M-K, Trotter, C, Vázquez, J A & Zhu, B 2019, ' The Global Meningococcal Initiative meeting on prevention of meningococcal disease worldwide : epidemiology, surveillance, hypervirulent strains, antibiotic resistance and high-risk populations ', Expert Review of Vaccines, vol. 18, no. 1, pp. 15-30 . https://doi.org/10.1080/14760584.2019.1557520Test
    Expert Review of Vaccines, 2018, 18 (1), pp.15-30. ⟨10.1080/14760584.2019.1557520⟩
    Repisalud
    Instituto de Salud Carlos III (ISCIII)

    وصف الملف: application/pdf

  6. 6

    المساهمون: Chinese Center for Disease Control and Prevention, Beijing Childrens Hospital, Manchester Royal Infirmary, University of Manchester [Manchester], Shanghai Municipal Center for Disease Control and Prevention, Huashan Hospital [Shangai], Center for Disease Control and Prevention [Liaoning], Centre National de Référence des Méningocoques et Haemophilus influenzae - National Reference Center Meningococci and Haemophilus influenzae (CNR), Institut Pasteur [Paris], Guangdong Provincial Center for Disease Control and Prevention, Institut Pasteur [Paris] (IP)

    المصدر: Journal of Infection
    Journal of Infection, WB Saunders, 2018, 76 (5), pp.429-437. ⟨10.1016/j.jinf.2018.01.007⟩
    Journal of Infection, 2018, 76 (5), pp.429-437. ⟨10.1016/j.jinf.2018.01.007⟩